retatrutide peptide clinical trial results ESC 2024: improves lipid and cardiovascular risk profile in Phase II Phase III retatrutide study demonstrates

Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack

Low B12 levels can contribute to fatigue, weakness, anemia, and neurological symptoms

Duffy AM, Holscher C

We agree with the applicant that the VersaVue TM Single-Use Flexible Cystoscope is not equipment, an instrument, apparatus, implement, or item of this type for which depreciation and financing expenses are recovered as depreciable assets, or a material or supply furnished incident to a service

Psychopharmacology 242:18 Geisler CE, Antonellis MP, Trumbauer W et al (2023) Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents

Hn na, sn phm khng cha cc cht c hi nn khng c tnh cht ty ra nn rt lnh tnh